The Missouri Court of Appeals refused to reverse a decision against chemical giant Givaudan Flavors Corporation. Givaudan challenged a jury verdict awarding James Graham damages for a serious lung disease caused by exposure to chemical flavoring agents. The appellate court affirmed the trial court’s judgment in full. In doing so, the courts upheld a massive victory for victims of workplace chemical exposure. Givaudan manufactured flavoring products containing diacetyl and 2,3-pentanedione, which were supplied to a General Mills plant where James Graham worked from 2005 to 2011. Graham was exposed to these chemicals in the workplace and later developed bronchiolitis obliterans, a severe and irreversible lung disease often referred to as ‘popcorn lung,’ that significantly reduced his lung capacity and quality of life.
Graham sued Givaudan, alleging that the company’s products, specifically exposure to diacetyl and/or 2,3-pentanedione, caused his illness. A jury awarded him $2 million in compensatory damages and approximately $56.6 million in punitive damages. After accounting for settlements with other defendants, the compensatory award was reduced to about $1.53 million.
Givaudan’s Attempted Appeal
Givaudan raised multiple claims of error, including:
- Improper admission of expert testimony
- Erroneous admission and exclusion of evidence
- Failure of Graham to establish a submissible case
- Improper award and excessiveness of punitive damages
- Failure to apply Missouri’s punitive damages cap
- Improper calculation of post-judgment interest
Court Upholds Expert Testimony Admission
The court upheld the admission of testimony from Graham’s experts finding that Dr. Adam Finkel’s testimony on general causation and workplace exposure was deemed reliable. The Court found that his methodology, based on scientific literature, workplace conditions, and accepted epidemiological principles met legal standards. Additionally, they determined that testimony submitted by Dr. Charles Pue, a pulmonologist, was correct. The court found that his use of differential diagnosis to determine causation was accepted as a reliable medical method. Any weaknesses in his conclusions affected weight, not admissibility. The appellate court concluded that the trial court did not abuse its discretion in admitting expert testimony.
Givaudan’s attempted to disqualify the medical expert by arguing that his methods weren’t clinically sound enough for the court room. This is a win for victims of industrial chemical exposures. By affirming that different diagnosis is a legally “reliable method”, future victims who have clear symptoms will be able to seek justice for their injuries.
Evidentiary Rulings
The court affirmed several key evidentiary decisions. The court found that evidence of similar lung injuries in other workers was properly admitted to show Givaudan had notice of the risk. The appellate showing supported the exclusion of evidence about cigarette smoke containing similar chemicals due to limited relevance and risk of confusing the jury. Additionally, they found that the lower court’s exclusion of other cases was either unsupported or not properly preserved for appeal.
Givaudan tried to argue that since cigarettes contain similar chemicals and don’t cause popcorn lung, that evidence should have been submitted. However, in this case, the concentration of diacetyl at the flavoring plant was much higher than what is found in a cigarette. Additionally, offering a plaintiff’s smoking history may have been an attempt to bias the jury based on character assassination. By excluding this evidence, the court forced the focus to remain on the industrial-grade toxins and not be distracted by the cigarette red herring.
Submissibility of the Case
Givaudan’s argument that Graham failed to present a sufficient case was rejected. The court found the argument procedurally defective and also determined that sufficient evidence supported the jury’s verdict, including proof of causation and knowledge of risk.
Punitive Damages
The court upheld the punitive damages award. For punitive damages to be submissible, there must be clear and convincing proof that the defendant intentionally acted ‘either by wanton, willful, or outrageous act, or reckless disregard for an act’s consequences.” The court found that Graham introduced evidence that by 1985 Givaudan was aware the chemicals could cause systemic toxicity and that by 2006 there was compelling scientific evidence linking occupational exposure of diacetyl to bronchiolitis obliterans. However, Givaudan did not place warning labels on its products until 2019. Evidence showed Givaudan knew for decades that its chemicals could cause serious lung disease but failed to adequately warn customers or take corrective action.
This and other evidence were considered sufficient for the jury to find that the continued marketing of diacetyl and 2,3 pentanedione for years after known toxicity and injury could reasonably be considered disregard of worker safety for profit.
The appellate court also found that the compensation for Graham’s serious injuries do not mitigate Givaudan’s liability for punitive damages. While Givaudan’s argued that the company’s net worth is not relevant to punitive damages was not relevant to its punitive damage liability, the court emphasized that “the threat of a punitive damages award needs to be great enough to dissuade a company from engaging in wrongdoing; it needs to be substantial enough to create a negative value proposition for the company.”
Finally, the court held that Missouri’s statutory cap on punitive damages did not apply.
Post-Judgment Interest
The court affirmed the award of post-judgment interest on the entire judgment, including punitive damages, even though a portion of those damages may be allocated to the state.
The Graham v. Givaudan verdict stands as a formidable warning to corporations that prioritize profit over the safety of their workforce. By successfully navigating the complexities of toxic tort litigation, specifically through the validation of differential diagnosis as reliable evidence and the strategic exclusion of misleading “alternative causation” arguments, the plaintiff’s team did more than just secure a massive financial judgment; they reinforced the legal accountability of chemical suppliers.
By focusing on the manufacturer’s decades of “willful and wanton” disregard for known risks rather than just the employer’s conduct, the legal team effectively bypassed the common pitfalls of worker’s compensation limitations. Ultimately, this ruling is a profound victory for justice, signaling that when companies bury scientific warnings for the sake of the bottom line, the legal system will act as a necessary and expensive corrective force.
